Profile: Sun Pharmaceutical Industries Ltd (SUN.NS)

SUN.NS on National Stock Exchange of India

878.90INR
5:28am EST
Change (% chg)

Rs13.20 (+1.52%)
Prev Close
Rs865.70
Open
Rs870.15
Day's High
Rs883.90
Day's Low
Rs868.55
Volume
2,160,310
Avg. Vol
1,858,518
52-wk High
Rs965.95
52-wk Low
Rs552.55

Search Stocks
Sun Pharmaceutical Industries Ltd. (Sun) is an international pharmaceutical company. The Company manufactures and markets a variety of pharmaceutical formulations as branded generics, as well as generics in the United States, India and several other global markets. It operates through four segments, including US Generics, Indian Branded Generics, International Branded Generics (rest of the world, except the United States) and Active Pharmaceutical Ingredients (API). The Company’s brands are prescribed in chronic therapy areas, such as psychiatry, neurology, cardiology, nephrology, gastroenterology, orthopedics and ophthalmology. Sun makes specialty APIs, including peptides, steroids, hormones and anticancers. The Company’s API products include Acamprosate Calcium, Alendronate Sodium, Bortezomib, Cisplatin, Choline Fenofibrate and Carvedilol. Its subsidiaries include Alkaloida Sweden AB, Chattem Chemicals Inc., Morley and Company Inc. and Sun Pharmaceutical UK Ltd.

Company Address

Sun Pharmaceutical Industries Ltd

Acme Plaza
Andheri - Kurla Rd, Andheri (E)
Andheri (East)
MUMBAI     400059
P: +9122.66969696
F: +9122.28212010

Company Web Links

Search Stocks